Safety and Efficacy of the Gastric Reactance (XL) in Patients Post-operated of Elective Cardiac Surgery

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

September 26, 2018

Primary Completion Date

December 28, 2019

Study Completion Date

December 28, 2019

Conditions
Cardiac FailureVentricular DysfunctionValvular Heart Disease
Interventions
DEVICE

Florence device

The Florence catheter will be placed at the beginning of the surgery and up to 72 hours in ICU.

Trial Locations (1)

14080

Instituto Nacional de Cardiología Ignacio Chávez, Tlalpan

All Listed Sponsors
collaborator

Instituto Nacional de Cardiologia Ignacio Chavez

OTHER

collaborator

National Council of Science and Technology, Mexico

OTHER

collaborator

Gerbera Capital

OTHER

collaborator

Alandra Medical SAPI de CV

INDUSTRY

lead

Critical Perfusion Inc.

INDUSTRY

NCT03799133 - Safety and Efficacy of the Gastric Reactance (XL) in Patients Post-operated of Elective Cardiac Surgery | Biotech Hunter | Biotech Hunter